These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1218 related articles for article (PubMed ID: 17420342)

  • 21. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
    Rodriguez-Pascual F; Miras-Portugal MT; Torres M
    Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathway.
    Andric SA; Janjic MM; Stojkov NJ; Kostic TS
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E544-50. PubMed ID: 20663985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans.
    Borlaug BA; Melenovsky V; Marhin T; Fitzgerald P; Kass DA
    Circulation; 2005 Oct; 112(17):2642-9. PubMed ID: 16246964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
    Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
    Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.
    Zhu CB; Hewlett WA; Feoktistov I; Biaggioni I; Blakely RD
    Mol Pharmacol; 2004 Jun; 65(6):1462-74. PubMed ID: 15155839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure.
    Senzaki H; Smith CJ; Juang GJ; Isoda T; Mayer SP; Ohler A; Paolocci N; Tomaselli GF; Hare JM; Kass DA
    FASEB J; 2001 Aug; 15(10):1718-26. PubMed ID: 11481219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.
    Mehel H; Emons J; Vettel C; Wittköpper K; Seppelt D; Dewenter M; Lutz S; Sossalla S; Maier LS; Lechêne P; Leroy J; Lefebvre F; Varin A; Eschenhagen T; Nattel S; Dobrev D; Zimmermann WH; Nikolaev VO; Vandecasteele G; Fischmeister R; El-Armouche A
    J Am Coll Cardiol; 2013 Oct; 62(17):1596-606. PubMed ID: 23810893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects.
    Werkström V; Svensson A; Andersson KE; Hedlund P
    BJU Int; 2006 Aug; 98(2):414-23. PubMed ID: 16626307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
    MacDonell KL; Diamond J
    Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes.
    Yamamoto K; Ikeda U; Shimada K
    J Mol Cell Cardiol; 1997 Sep; 29(9):2375-82. PubMed ID: 9299361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
    Ferreira-Melo SE; Yugar-Toledo JC; Coelho OR; De Luca IM; Tanus-Santos JE; Hyslop S; Irigoyen MC; Moreno H
    Eur J Pharmacol; 2006 Aug; 542(1-3):141-7. PubMed ID: 16806160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
    Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception.
    Patil CS; Jain NK; Singh VP; Kulkarni SK
    Indian J Exp Biol; 2004 Apr; 42(4):361-7. PubMed ID: 15088685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes.
    Geng Y; Zhou L; Thompson WJ; Lotz M
    J Biol Chem; 1998 Oct; 273(42):27484-91. PubMed ID: 9765278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
    Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
    Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide regulation of cGMP production in osteoclasts.
    Dong SS; Williams JP; Jordan SE; Cornwell T; Blair HC
    J Cell Biochem; 1999 Jun; 73(4):478-87. PubMed ID: 10733342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response.
    Sterin-Borda L; Bernabeo G; Ganzinelli S; Joensen L; Borda E
    J Mol Cell Cardiol; 2006 Apr; 40(4):580-8. PubMed ID: 16510153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide.
    Hotston MR; Jeremy JY; Bloor J; Koupparis A; Persad R; Shukla N
    BJU Int; 2007 Mar; 99(3):612-8. PubMed ID: 17176295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide modulation of agonist-evoked intracellular Ca2+ release in neurosecretory PC-12 cells: inhibition of phospholipase C activity via cyclic GMP-dependent protein kinase I.
    Clementi E; Vecchio I; Sciorati C; Nisticò G
    Mol Pharmacol; 1995 Mar; 47(3):517-24. PubMed ID: 7535379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.